DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $142,264,315 | -30.1% | 6,895,992 | 0.0% | 0.85% | -28.1% |
| Q2 2023 | $203,500,724 | +28.1% | 6,895,992 | 0.0% | 1.18% | +24.9% |
| Q1 2023 | $158,883,656 | -12.3% | 6,895,992 | +5.8% | 0.94% | -11.0% |
| Q4 2022 | $181,211,100 | +5.9% | 6,516,041 | +16.9% | 1.06% | +3.4% |
| Q3 2022 | $171,128,698 | +8.3% | 5,576,041 | +3.8% | 1.02% | +18.2% |
| Q2 2022 | $158,024,002 | -8.5% | 5,369,487 | 0.0% | 0.87% | +19.0% |
| Q1 2022 | $172,736,397 | -27.9% | 5,369,487 | 0.0% | 0.73% | -15.7% |
| Q4 2021 | $239,479,000 | -11.6% | 5,369,487 | 0.0% | 0.86% | -8.9% |
| Q3 2021 | $270,891,000 | -21.7% | 5,369,487 | +21.7% | 0.95% | -18.1% |
| Q2 2021 | $345,956,000 | +37.4% | 4,410,457 | 0.0% | 1.16% | +17.3% |
| Q1 2021 | $251,837,000 | -31.8% | 4,410,457 | 0.0% | 0.99% | -37.8% |
| Q4 2020 | $369,420,000 | +133.8% | 4,410,457 | 0.0% | 1.59% | +97.9% |
| Q3 2020 | $158,027,000 | +48.2% | 4,410,457 | 0.0% | 0.80% | +25.9% |
| Q2 2020 | $106,645,000 | +38.1% | 4,410,457 | 0.0% | 0.64% | +12.0% |
| Q1 2020 | $77,227,000 | +0.5% | 4,410,457 | 0.0% | 0.57% | +13.3% |
| Q4 2019 | $76,830,000 | +13.7% | 4,410,457 | 0.0% | 0.50% | +1.4% |
| Q3 2019 | $67,568,000 | -26.2% | 4,410,457 | 0.0% | 0.50% | -24.3% |
| Q2 2019 | $91,561,000 | -10.6% | 4,410,457 | 0.0% | 0.65% | -7.8% |
| Q1 2019 | $102,411,000 | +12.4% | 4,410,457 | 0.0% | 0.71% | +13.1% |
| Q4 2018 | $91,120,000 | -5.0% | 4,410,457 | 0.0% | 0.63% | +12.4% |
| Q3 2018 | $95,883,000 | +42.6% | 4,410,457 | 0.0% | 0.56% | +57.6% |
| Q2 2018 | $67,259,000 | -22.6% | 4,410,457 | 0.0% | 0.35% | -25.6% |
| Q1 2018 | $86,842,000 | +25.9% | 4,410,457 | 0.0% | 0.48% | +12.3% |
| Q4 2017 | $68,980,000 | – | 4,410,457 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |